Defining the appropriate patient population for primary brachytherapy for localized prostate cancer: work in progress

Mayo Clin Proc. 2004 Mar;79(3):307-8. doi: 10.4065/79.3.307.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adenocarcinoma / physiopathology
  • Adenocarcinoma / therapy*
  • Brachytherapy / adverse effects*
  • Humans
  • Iodine Radioisotopes / therapeutic use
  • Male
  • Palladium / therapeutic use
  • Prostatic Neoplasms / physiopathology
  • Prostatic Neoplasms / therapy*
  • Radioisotopes / therapeutic use
  • Risk Factors

Substances

  • Iodine Radioisotopes
  • Radioisotopes
  • Palladium